SynBioBeta

Are you ready to join the ultimate gathering of bio geeks and changemakers? 🧪 SynBioBeta 2025 is where the synthetic biology community meets to share ideas, spark innovation, and build the future. Be part of the conversation—register today: https://loom.ly/gM9JE9M #SynBioBeta2025 #SyntheticBiology

While the world focused on COVID-19, another pandemic continued to claim lives in silence. Tuberculosis (TB) remains the leading infectious cause of death globally, killing 1.3 million people every year—more than HIV/AIDS and malaria combined. For over a century, we've relied on the BCG vaccine, but its effectiveness has been limited. Now, a new mRNA-based TB vaccine might be the breakthrough we've been waiting for. 💉 Developed by researchers at the University of Sydney’s Sydney Infectious Diseases Institute, the Centenary Institute, and Monash University, this vaccine has already shown promising results in preclinical trials—triggering strong immune responses and reducing TB bacteria in infected mice. If successful in humans, this could revolutionize TB prevention worldwide. learn more: https://lnkd.in/e6TAmrA4 #Tuberculosis #VaccineBreakthrough #mRNA #GlobalHealth #MedicalInnovation

What if a common herbal tea ingredient could transform modern medicine? A PhD student at UChicago has done just that! 💡 Changxu Sun and his team at Pritzker School of Molecular Engineering at the University of Chicago have unlocked the potential of malva nuts—a traditional Chinese medicine ingredient—to create a powerful hydrogel with groundbreaking medical applications. learn more: https://lnkd.in/gzzHKxdv #MedicalInnovation #Biomaterials #ScienceBreakthrough #UChicago #HydrogelTech

Join #SynBioBeta2025 this May and connect with leading minds in biotech and innovation. 📅 May 5–8, 2025 📍 San Jose Convention Center, California Get your ticket today: https://lnkd.in/genxNn67

🔬✨ Evo 2: One Bio-AI Model to Rule Them All A groundbreaking collaboration between Arc Institute & NVIDIA, Evo 2 is trained on DNA from 100,000+ species—detecting disease mutations and even designing new genomes. “Machines can now read, write, and think in the language of nucleotides,” says Patrick Hsu, Arc Institute Co-Founder. Brian Hie, Arc Institute Innovation Investigator, adds: “These patterns, refined over millions of years, contain signals about how molecules work and interact.” learn more: https://lnkd.in/grYEsnwf #AI #Biotech #Evo2 #Innovation #NVIDIA #ArcInstitute

We are excited to share a fantastic opportunity for a Microbial Molecular Biologist/Strain Engineer at Peptobiotics! If you have a PhD and up to two years of experience, this role could be just what you are looking for. What You Will Be Doing: - Working on product development and innovation - Leading a small team - Writing and filing patents - Engineering yeast strains for production at a 40,000L scale If you or anyone you know is interested, feel free to reach out to jobs@peptobiotics.com! #Hiring #Biotech #MolecularBiology #MicrobialBiology #JobAlert

🚀 SynBioBeta 2025 Event Agenda is Here! 📅 Everything you need to know—all in one place! It includes: - Expert Speakers - Track Chairs - Daily Agenda - Sponsors & Exhibitors - Networking & Special Events Access the full agenda: https://lnkd.in/gGKVxA-B #SynBioBeta2025 #BiotechInnovation #FutureOfBiotech

E-Skin That Heals in Seconds! ⏳✨ Self-healing electronic skin repairs itself in seconds, making wearable tech finally practical for real-world use. learn more: https://lnkd.in/gxnkfeGR #WearableTech #HealthTech

Breakthrough in Rapid Protein Production Scientists from Duke University have engineered synthetic biological compartments that trap cellular machinery, significantly boosting protein production. These reaction crucibles streamline the process, enabling faster and more efficient synthesis for medical and industrial applications. 🚀🔬 read more: https://lnkd.in/g49ArQti #BiotechInnovation #ProteinSynthesis #SyntheticBiology #GeneticEngineering

Welcome our exhibitor and sponsor at #SynBioBeta2025 this May in San Jose! With a relentless mission to empower those seeking answers to life’s important scientific questions, Beckman Coulter Life Sciences is a preferred laboratory partner providing automation and innovation solutions for Centrifugation, Flow Cytometry, Genomics, Particle Analysis, and Liquid Handling workflows. With a legacy dating back to 1935, their technologies reduce manual laboratory processes and can provide greater speed, accuracy, and advanced analytics to accelerate answers with a guiding focus to improve patient care and enable pioneering discoveries. Beckman Coulter Life Sciences is headquartered in Indianapolis, Indiana with 11 operational hubs around the world and employs approximately 2,800 associates with more than 400,000 systems installed globally.